{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:42:01Z","timestamp":1791236521994,"version":"4.1.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N006445\/1"],"award-info":[{"award-number":["MR\/N006445\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,12,20]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Crohn\u2019s disease (CD) is a chronic, immune-mediated inflammatory bowel disease (IBD), presenting with symptoms of abdominal pain and bleeding from the gastrointestinal tract. There is no known cure. In vitro-expanded \u2018thymus-derived\u2019 regulatory T cells (tTreg) have shown promise in preclinical models of IBD, leading to interest in their use as a potential therapy in CD. We present a study protocol for a first-in-human study of Tregs for IBD using ex vivo Treg expansion. This study will explore the preliminary safety and tolerability of a single dose of Treg immunotherapy and will inform the design of a subsequent larger trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Four patients will be recruited from gastroenterology clinics at Guy\u2019s and St Thomas\u2019 NHS Foundation Trust. Eligible participants are those who are at least 18 years old, have a diagnosis of active moderate to severe CD and have failed to respond to or tolerate at least two prior lines of standard medication. Participants receive a single dose of autologous ex vivo-expanded Tregs and will be followed up to week 21 to collect safety and exploratory efficacy data. Additional safety monitoring will occur at 1 and 2\u2009years post-dose. The primary endpoint is defined as the occurrence of dose-limiting toxicity occurring within 5\u2009weeks post-infusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol and related documents have been approved by a NHS Research Ethics Committee, the Health Research Authority and the Medicines and Healthcare products Regulatory Agency for Clinical Trial Authorisation. It is intended that the results of the trial will be presented at international conferences and will be submitted for publication in a peer-reviewed scientific journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03185000\">NCT03185000<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-092733","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:46:25Z","timestamp":1737679585000},"page":"e092733","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE)"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct03185000","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Beverley","family":"Rodger","sequence":"first","affiliation":[{"name":"King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Clough","sequence":"additional","affiliation":[{"name":"King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Vasconcelos","sequence":"additional","affiliation":[{"name":"Dept of Primary Care and Public Health Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Canavan","sequence":"additional","affiliation":[{"name":"King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Macallan","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medicine, St. George\u2019s Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1723-0796","authenticated-orcid":false,"given":"A Toby","family":"Prevost","sequence":"additional","affiliation":[{"name":"Cicely Saunders Institute, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham M","family":"Lord","sequence":"additional","affiliation":[{"name":"MRC Centre for Transplantation, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Irving","sequence":"additional","affiliation":[{"name":"King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025121514043255000_15.1.e092733.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311894"},{"key":"2025121514043255000_15.1.e092733.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.06.001"},{"key":"2025121514043255000_15.1.e092733.3","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.4.2579"},{"key":"2025121514043255000_15.1.e092733.4","doi-asserted-by":"publisher","DOI":"10.1038\/nri2785"},{"key":"2025121514043255000_15.1.e092733.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.03.019"},{"key":"2025121514043255000_15.1.e092733.6","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e328317a476"},{"key":"2025121514043255000_15.1.e092733.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00250.x"},{"key":"2025121514043255000_15.1.e092733.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2008.01.004"},{"key":"2025121514043255000_15.1.e092733.9","doi-asserted-by":"publisher","DOI":"10.1038\/ni1536"},{"key":"2025121514043255000_15.1.e092733.10","doi-asserted-by":"crossref","first-page":"S672","DOI":"10.21037\/tcr.2016.10.47","article-title":"Tregs, Helios and tumor immunity: the sun has not yet risen","volume":"5","author":"Thornton","year":"2016","journal-title":"Transl Cancer Res"},{"key":"2025121514043255000_15.1.e092733.11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4376"},{"key":"2025121514043255000_15.1.e092733.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.043"},{"key":"2025121514043255000_15.1.e092733.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.08.003"},{"key":"2025121514043255000_15.1.e092733.14","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.551887"},{"key":"2025121514043255000_15.1.e092733.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.12.053"},{"key":"2025121514043255000_15.1.e092733.16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12931212"},{"key":"2025121514043255000_15.1.e092733.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2010.04.014"},{"key":"2025121514043255000_15.1.e092733.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.017"},{"key":"2025121514043255000_15.1.e092733.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.02.019"},{"key":"2025121514043255000_15.1.e092733.20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.8.3939"},{"key":"2025121514043255000_15.1.e092733.21","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/5.11.1461"},{"key":"2025121514043255000_15.1.e092733.22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.1.237"},{"key":"2025121514043255000_15.1.e092733.23","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181ff8772"},{"key":"2025121514043255000_15.1.e092733.24","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2154"},{"key":"2025121514043255000_15.1.e092733.25","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bbmt.2017.07.009","article-title":"Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models","volume":"23","author":"Del Papa","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025121514043255000_15.1.e092733.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-293795"},{"key":"2025121514043255000_15.1.e092733.27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"2025121514043255000_15.1.e092733.28","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0038"},{"key":"2025121514043255000_15.1.e092733.29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.074088"},{"key":"2025121514043255000_15.1.e092733.30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306919"},{"key":"2025121514043255000_15.1.e092733.31","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.041483"},{"key":"2025121514043255000_15.1.e092733.32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature New Biol"},{"key":"2025121514043255000_15.1.e092733.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04037.x"},{"key":"2025121514043255000_15.1.e092733.34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.025"},{"key":"2025121514043255000_15.1.e092733.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015868","article-title":"Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells","volume":"6","author":"Golovina","year":"2011","journal-title":"PLoS One"},{"key":"2025121514043255000_15.1.e092733.36","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","article-title":"Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo","volume":"152","author":"Hamann","year":"1994","journal-title":"J Immunol"},{"key":"2025121514043255000_15.1.e092733.37","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2009.117"},{"key":"2025121514043255000_15.1.e092733.38","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and Reliability of the US National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-092733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:04:40Z","timestamp":1765836280000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-092733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,23]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-092733"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-092733","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}